ACA
HALO icon

Aptus Capital Advisors’s Halozyme HALO Stock Holding History

Aptus Capital Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$209K Buy
+2,675
New +$182K ﹤0.01% 1102

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Aptus Capital Advisors's HALO Position: Q2 2026 in Review

Aptus Capital Advisors opened a new position in Halozyme (HALO) in Q2 2026: 2,675 shares worth $209K. The stake represents ﹤0.01% of the portfolio and ranks #1102 among its holdings.

668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Aptus Capital Advisors held 2,675 shares of Halozyme worth $209K as of Q2 2026.
  • Halozyme was a new Aptus Capital Advisors position in Q2 2026.
  • Halozyme made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #1102 holding.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.